Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Net Margin (2024)

Compass Therapeutics' Net Margin history spans 1 years, with the latest figure at 1538.35% for Q2 2024.

  • On a quarterly basis, Net Margin changed N/A to 1538.35% in Q2 2024 year-over-year; TTM through Jun 2025 was 7824.94%, a 226706.0% decrease, with the full-year FY2024 number at 6661.76%, changed N/A from a year prior.
  • Net Margin hit 1538.35% in Q2 2024 for Compass Therapeutics.
  • Over the last five years, Net Margin for CMPX hit a ceiling of 1538.35% in Q2 2024 and a floor of 1538.35% in Q2 2024.